NU-1223 is an experimental drug from the β-carboline family, which is thought to act as a selective agonist of the 5-HT2C receptor. It has been investigated for possible applications in the treatment of schizophrenia.
See also Substituted β-carboline Alstonine Harmine LY-266,097 LY-272,015 Fenharmane 1-(2,4,5-Trimethoxyphenyl)-6-chlorotryptoline
References